Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Coherus Biosciences Inc (NASDAQ: CHRS) was $1.80 for the day, up 9.09% from the previous closing price of $1.65. In other words, the price has increased by $9.09 from its previous closing price. On the day, 2.07 million shares were traded. CHRS stock price reached its highest trading level at $1.8 during the session, while it also had its lowest trading level at $1.66.
Ratios:
Our analysis of CHRS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.05 and its Current Ratio is at 1.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on November 17, 2023, initiated with a Outperform rating and assigned the stock a target price of $11.
On July 24, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $12.Citigroup initiated its Buy rating on July 24, 2023, with a $12 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 22 ’23 when Lanfear Dennis M sold 223,100 shares for $2.02 per share. The transaction valued at 449,770 led to the insider holds 731,693 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRS now has a Market Capitalization of 206506800 and an Enterprise Value of 427894336. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68. Its current Enterprise Value per Revenue stands at 1.417 whereas that against EBITDA is -2.732.
Stock Price History:
The Beta on a monthly basis for CHRS is 0.60, which has changed by -0.5890411 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, CHRS has reached a high of $5.47, while it has fallen to a 52-week low of $1.25. The 50-Day Moving Average of the stock is -0.65%, while the 200-Day Moving Average is calculated to be -23.73%.
Shares Statistics:
CHRS traded an average of 1.64M shares per day over the past three months and 1892280 shares per day over the past ten days. A total of 112.22M shares are outstanding, with a floating share count of 110.09M. Insiders hold about 4.04% of the company’s shares, while institutions hold 69.93% stake in the company. Shares short for CHRS as of 1719532800 were 23035773 with a Short Ratio of 14.02, compared to 1717113600 on 22059119. Therefore, it implies a Short% of Shares Outstanding of 23035773 and a Short% of Float of 23.45.
